A clinical trial for breast implants is a research study where people volunteer to test new or modified breast implant designs, materials, or surgical techniques. Unlike a standard cosmetic surgery procedure, clinical trials are structured research projects that follow strict protocols approved by medical review boards. The goal isn't primarily to provide cosmetic results—it's to gather safety and effectiveness data that the FDA and manufacturers use to understand how implants perform over time.
Learn About Paying Your FGUA Bill Online →
Breast implant trials typically fall into several categories. Some studies test brand-new implant materials or designs that haven't been used in humans before. Others monitor the long-term outcomes of implants already on the market, tracking how they hold up over 5, 10, or even 20 years. A third type compares different surgical techniques—for example, testing whether placing an implant above or below the chest muscle affects outcomes differently. Some trials focus on specific populations, such as women reconstructing after cancer surgery versus those seeking cosmetic enhancement.
The companies manufacturing implants—firms like Allergan, Mentor, Sientra, and others—sponsor many of these trials. However, the research doesn't belong to them. Independent researchers at universities and medical centers often run the actual studies, and the FDA oversees the process. This separation of interests is built into the system to keep the focus on safety rather than sales.
One important distinction: participating in a clinical trial is different from getting a cosmetic procedure done. You're contributing data to medical knowledge. The surgeon may not prioritize your aesthetic preferences the same way they would in a paid cosmetic surgery. You may also need to follow specific post-surgery protocols, attend more follow-up appointments than usual, and potentially undergo imaging (mammograms, ultrasounds, MRIs) at set intervals. These requirements exist to collect consistent, comparable data across all trial participants.
Practical takeaway: Understand that a clinical trial is fundamentally a research partnership, not a cosmetic service. The primary purpose is generating data, and your participation involves obligations and monitoring beyond a standard procedure.
The FDA's role in breast implant clinical trials is substantial and ongoing. Before any company can test a new implant design in human subjects, the manufacturer must submit a detailed plan called an Investigational Device Exemption (IDE) application. This application includes laboratory testing results, animal study data (if applicable), and a proposed study protocol explaining exactly how the trial will run, who can participate, what measurements will be taken, and what risks are being monitored.
Free Guide to Pay by Plate Illinois Billing →
The FDA reviews this submission and decides whether the proposed trial is safe enough to begin. They examine the implant's materials, manufacturing process, design features, and the company's plan for monitoring participant safety. If the FDA approves the IDE, the company receives permission to test the device in human subjects—but only under the conditions specified in that approval. The manufacturer cannot simply change the study design or recruit different people without FDA notification.
Throughout the trial, the FDA requires ongoing safety reporting. If serious adverse events occur—such as implant rupture, infection, or unexpected tissue reactions—the manufacturer must report these to the FDA within specific timeframes. The FDA can inspect trial sites to verify that researchers are following the approved protocol and properly documenting results. They can also halt a trial if safety concerns emerge.
Once a trial concludes, the manufacturer compiles all the data into a Premarket Approval (PMA) application, which is a more comprehensive submission requesting FDA clearance for the implant to be marketed and sold. The FDA reviews this data, sometimes requests additional studies, and makes a decision. Notably, the FDA's approval process for breast implants is typically more rigorous than for some other medical devices because breast implants are long-term implants in healthy tissue.
Another layer of oversight comes from Institutional Review Boards (IRBs) at each trial site. These are independent committees—usually made up of doctors, scientists, and community members—that review the study plan before it starts and monitor it while it's running. They ensure the research is ethical and that participants' rights are protected. An IRB can also stop a trial if they determine participants aren't being adequately protected.
Practical takeaway: Multiple independent organizations oversee breast implant trials. The FDA, manufacturers, hospitals, and local review boards all have roles in monitoring safety and ensuring the study follows its approved plan.
Breast implant clinical trials vary significantly depending on what question the research is trying to answer. Understanding the different types helps you grasp what data is actually being collected and why certain follow-up visits might be required.
Free Guide to Mold Removal Methods for Walls →
Safety and tolerability studies focus on whether the implant material and design can remain in the body without causing serious reactions. Researchers monitor for capsular contracture (hardening of the scar tissue around the implant), implant rupture, rippling, infections, and systemic symptoms that patients report. These trials typically last several years and include regular physical exams, imaging studies, and patient questionnaires. For example, a trial might require participants to return at 3 months, 6 months, 1 year, 2 years, and 5 years post-surgery for examination and imaging.
Comparative effectiveness trials test two or more approaches against each other. A trial might randomly assign participants to receive implants placed either above or below the pectoral muscle, then track outcomes over several years to see which placement results in fewer complications or better patient satisfaction. Another comparison trial might test different implant shapes—round versus anatomical (teardrop-shaped)—to see which produces more natural-looking results and which experiences more problems.
Imaging studies focus specifically on how implants appear on mammography, ultrasound, and MRI. Since breast cancer screening is a concern for women with implants, researchers want to understand how implants affect imaging quality and whether they obscure areas where cancer might develop. These trials involve repeated imaging procedures, sometimes comparing different imaging techniques or technologies.
Long-term surveillance studies follow women who received implants years earlier—sometimes 10, 15, or 20 years post-surgery. These observational studies track how implants hold up over decades. Participants may not have surgical procedures; they simply return for periodic exams and imaging. These studies have revealed important information about implant rupture rates, the timeline for complications, and whether any health issues emerge over extended time periods.
Specialized population trials focus on specific groups. For instance, a trial might study only women undergoing breast reconstruction after cancer surgery, or only women with a family history of connective tissue disease. These studies help researchers understand whether implants perform differently depending on the person's medical background or the reason for surgery.
Practical takeaway: Each trial type measures different outcomes and requires different levels of participant involvement. Knowing what type of trial you're considering tells you what kind of monitoring and follow-up to expect.
Participating in a breast implant clinical trial requires a significant commitment that extends well beyond the surgery itself. This section breaks down the realistic expectations so you understand the full scope of involvement.
How to Delete Your Fitbit Account Guide →
The surgical procedure itself may differ from what you'd experience in a private cosmetic surgery setting. The surgeon follows a detailed, standardized protocol—specific incision locations, specific implant placement techniques, specific closure methods. While the surgeon is skilled and the procedure is safe, the technique may not match what you might otherwise prefer. For example, if you prefer a particular incision location but the trial protocol specifies a different location, you follow the protocol.
Pre-surgery appointments are more extensive in trials. You'll have baseline evaluations, imaging studies (usually mammograms and ultrasounds), physical exams documenting your current breast anatomy, and possibly blood work. You'll also sign detailed consent forms explaining the study, its risks, and your rights. Some trials require psychological evaluation or assessment to ensure you understand you're in a research study and aren't participating primarily for cosmetic reasons.
Post-surgery follow-up is more frequent and structured. A typical trial might require visits at 1 week, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years, and 5 years post-surgery. At each visit, you'll undergo physical examination, possibly imaging studies, and questionnaires about how you're feeling, any symptoms you've experienced, and your satisfaction with the results. Some trials require annual visits indefinitely.
Imaging studies are standard in most trials. This may
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.